A41
Conditions
Interventions
Group 1: Methodik
per patient 4 blood collection time points
per time point quantification of capillary perfusion (O2C) and coagulation (global parameters, thrombelastography), NET-quantification (flowzytometry), measurement of ROS-activity (ESR) und quantifica
2. SIRS following major surgery
3. SIRS following cardiopulmonary bypass
Sponsors
Universitätsklinikum Gießen und Marburg, Standort GießenKlinik für Anästhesiologie, operative Intensivmedizin und Schmerztherapie
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: age>18 years signed informed consent
Exclusion criteria
Exclusion criteria: age <18 years, pregnancy, severe valvular heart disease (III°), active autoimmune disorders, active solid or hematogenic malignancies, disorders with need of immunosuppressive therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NETs in peripheral blood (quantified with flow cytometry) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Severity of coagulopathy (thrombelastography) 2. Amount of free circulating mitochondrial DNA (qPCR) 3. mount of free circulating and mitochondrial ROS (ESR) 4. Severity of peripheral perfusion problems (O2C) | — |
Countries
Germany
Contacts
Public ContactMichael Sander
Klinik für Anästhesiologie, operative Intensivmedizin und Schmerztherapie
Outcome results
None listed